8-K/A XBRL

8-K/A

Company: Viridian Therapeutics, Inc.\DE
Filed: October 1, 2020
Period of Report: September 13, 2020
Accession Number: 0001590750-20-000088

View Document ↗ View on SEC.gov ↗